Acanthamoeba and the blood–brain barrier: the breakthrough

References

1. Alsam S., Kim K. S., Stins M., Rivas A. O., Sissons J., Khan N. A. 2003; Acanthamoeba interactions with human brain microvascular endothelial cells. Microb Pathog 35:235–241 [CrossRef]
   [Google Scholar]
2. Alsam S., Sissons J., Dudley R., Khan N. A. 2005a; Mechanisms associated with Acanthamoeba castellanii (T4) phagocytosis. Parasitol Res 96:402–409 [CrossRef]
   [Google Scholar]
3. Alsam S., Sissons J., Jayasekera S., Khan N. A. 2005b; Extracellular proteases of Acanthamoeba castellanii (encephalitis isolate belonging to T1 genotype) contribute to increased permeability in an in vitro model of the human blood–brain barrier. J Infect 51:150–156 [CrossRef]
   [Google Scholar]
4. Benedetto N., Auriault C. 2002a; Prolactin-cytokine network in defence against Acanthamoeba castellanii in murine microglia. Eur Cytokine Netw 13:447–455
   [Google Scholar]
5. Benedetto N., Auriault C. 2002b; Complex network of cytokines activating murine microglial cell activity against Acanthamoeba castellanii . Eur Cytokine Netw 13:351–357
   [Google Scholar]
6. Benedetto N., Rossano F., Gorga F., Folgore A., Rao M., Carratelli C. R. 2003; Defense mechanisms of IFN- γ and LPS-primed murine microglia against Acanthamoeba castellanii infection. Int Immunopharmacol 3:825–834 [CrossRef]
   [Google Scholar]
7. Cerva L. 1967; Intranasal, intrapulmonary and intracardial inoculation of experimental animals with Hartmanella castellanii . Folia Parasitol (Praha 14:207–215
   [Google Scholar]
8. Culbertson C. G., Smith J. W., Cohen H. K., Minner J. R. 1959; Experimental infection of mice and monkeys by Acanthamoeba . Am J Pathol 35:185–197
   [Google Scholar]
9. Garate M., Cao Z., Bateman E., Panjwani N. 2004; Cloning and characterization of a novel mannose-binding protein of Acanthamoeba . J Biol Chem 279:29849–29856 [CrossRef]
   [Google Scholar]
10. Graff C. L., Pollack G. M. 2005; Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci 94:1187–1195 [CrossRef]
    [Google Scholar]
11. Huber J. D., Egleton R. D., Davis T. P. 2001; Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24:719–725 [CrossRef]
    [Google Scholar]
12. Illum L. 2000; Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1–18 [CrossRef]
    [Google Scholar]
13. Jinga V. V., Gafencu A., Antohe F., Constantinescu E., Heltianu C., Raicu M., Manolescu I., Hunziker W., Simionescu M. 2000; Establishment of a pure vascular endothelial cell line from human placenta. Placenta 21:325–336 [CrossRef]
    [Google Scholar]
14. Khan N. A. 2001; Pathogenicity, morphology and differentiation of Acanthamoeba . Curr Microbiol 43:391–395 [CrossRef]
    [Google Scholar]
15. Khan N. A. 2006; Acanthamoeba : biology and increasing importance in human health. FEMS Microbiol Rev 30:564–595 [CrossRef]
    [Google Scholar]
16. Khan N. A. 2007; Acanthamoeba invasion of the central nervous system. Int J Parasitol 37:131–138 [CrossRef]
    [Google Scholar]
17. Kim J. H., Kim J. H., Park J. A., Lee S., Kim W. J., Yu Y. S., Kim K. 2006; Blood-neural barrier: intercellular communication at glio-vascular interface. J Biochem Mol Biol 39:339–345 [CrossRef]
    [Google Scholar]
18. Kong H. H., Kim T. H., Chung D. I. 2000; Purification and characterization of a secretory proteinase of Acanthamoeba healyi isolates from GAE. J Parasitol 86:12–17 [CrossRef]
    [Google Scholar]
19. Marciano-Cabral F., Cabral G. 2003; Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 16:273–307 [CrossRef]
    [Google Scholar]
20. Marciano-Cabral F., Puffenbarger R., Cabral G. A. 2000; The increasing importance of Acanthamoeba infections. J Eukaryot Microbiol 47:29–36 [CrossRef]
    [Google Scholar]
21. Marciano-Cabral F., Ludwick C., Puffenbarger R. A., Cabral G. A. 2004; Differential stimulation of microglial pro-inflammatory cytokines by Acanthamoeba culbertsoni versus Acanthamoeba castellanii . J Eukaryot Microbiol 51:472–479 [CrossRef]
    [Google Scholar]
22. Martinez A. J. 1985 Free-living Amebas: Natural History, Prevention, Diagnosis, Pathology and Treatment of Disease Boca Raton, FL: CRC Press;
    [Google Scholar]
23. Martinez A. J. 1991; Infections of the central nervous system due to Acanthamoeba . Rev Infect Dis 13:S399–S402 [CrossRef]
    [Google Scholar]
24. Martinez A. J., Visvesvara G. S. 1997; Free-living, amphizoic and opportunistic amebas. Brain Pathol 7:583–598 [CrossRef]
    [Google Scholar]
25. Martinez A. J., Markowitz S. M., Duma R. J. 1975; Experimental pneumonitis and encephalitis caused by Acanthamoeba in mice: pathogenesis and ultrastructural features. J Infect Dis 131:692–699 [CrossRef]
    [Google Scholar]
26. Mattana A., Cappai V., Alberti L., Serra C., Fiori P. L., Cappuccinelli P. 2002; ADP and other metabolites released from Acanthamoeba castellanii lead to human monocytic cell death through apoptosis and stimulate the secretion of proinflammatory cytokines. Infect Immun 70:4424–4432 [CrossRef]
    [Google Scholar]
27. Miller D. W. 1999; Immunobiology of the blood-brain barrier. J Neurovirol 5:570–578 [CrossRef]
    [Google Scholar]
28. Pardridge W. M. 1999; Blood–brain barrier: biology and methodology. J Neurovirol 5:556–569 [CrossRef]
    [Google Scholar]
29. Pardridge W. M. 2002; Drug and gene delivery to the brain: the vascular route. Neuron 36:555–558 [CrossRef]
    [Google Scholar]
30. Petry F., Torzewski M., Bohl J., Wilhelm-Schwenkmezger T., Scheid P., Walochnik J., Michel R., Zöller L., Werhahn K. J. other authors 2006; Early diagnosis of Acanthamoeba infection during routine cytological examination of cerebrospinal fluid. J Clin Microbiol 44:1903–1904 [CrossRef]
    [Google Scholar]
31. Pettit D. A., Williamson J., Cabral G. A., Marciano-Cabral F. 1996; In vitro destruction of nerve cell cultures by Acanthamoeba spp.: a transmission and scanning electron microscopy study. J Parasitol 82:769–777 [CrossRef]
    [Google Scholar]
32. Shen L., Black E. D., Witkowski E. D., Lencer W. I., Guerriero V., Schneeberger E. E., Turner J. R. 2006; Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 119:2095–2106 [CrossRef]
    [Google Scholar]
33. Shin H. J., Cho M. S., Jung S. Y., Kim H. I., Park S., Seo J. H., Yoo J. C., Im K. I. 2001; Cytopathic changes in rat microglial cells induced by pathogenic Acanthamoeba culbertsoni : morphology and cytokine release. Clin Diagn Lab Immunol 8:837–840
    [Google Scholar]
34. Sissons J., Alsam S., Jayasekera S., Kim K. S., Stins M., Khan N. A. 2004; Acanthamoeba induces cell-cycle arrest in the host cells. J Med Microbiol 53:711–717 [CrossRef]
    [Google Scholar]
35. Sissons J., Kim K. S., Stins M., Jayasekera S., Alsam S., Khan N. A. 2005; Acanthamoeba castellanii induces host cell death via a phosphatidylinositol 3-kinase-dependent mechanism. Infect Immun 73:2704–2708 [CrossRef]
    [Google Scholar]
36. Sissons J., Alsam S., Goldsworthy G., Lightfoot M., Jarroll E. L., Khan N. A. 2006; Identification and properties of proteases from an Acanthamoeba isolate capable of producing granulomatous encephalitis. BMC Microbiol 6:42 [CrossRef]
    [Google Scholar]
37. Stins M. F., Gilles F., Kim K. S. 1997; Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 76:81–90 [CrossRef]
    [Google Scholar]
38. Tuomanen E. 1996; Entry of pathogens into the central nervous system. FEMS Microbiol Rev 18:289–299 [CrossRef]
    [Google Scholar]
39. Visvesvara G. S., Moura H., Schuster F. L. 2007; Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri , and Sappinia diploidea . FEMS Immunol Med Microbiol 50:1–26 [CrossRef]
    [Google Scholar]